Cargando…
Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with Blepharospasm
BACKGROUND: XCiDaBLE is a large, prospective, observational “naturalistic” study evaluating Xeomin® for Cervical Dystonia or BLEpharospasm in the United States. We report the interim results from the blepharospasm cohort of XCiDaBLE. METHODS: Subjects (≥18 years old) with blepharospasm were followed...
Autores principales: | Fernandez, Hubert H., Jankovic, Joseph, Holds, John B., Lin, Daniel, Burns, John, Verma, Amit, Sethi, Kapil, Pappert, Eric J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia University Libraries/Information Services
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107228/ https://www.ncbi.nlm.nih.gov/pubmed/25120942 http://dx.doi.org/10.7916/D8MK6B1B |
Ejemplares similares
-
Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical Dystonia
por: Fernandez, Hubert H., et al.
Publicado: (2013) -
Profile of Xeomin(®) (incobotulinumtoxinA) for the treatment of blepharospasm
por: Park, Juwan, et al.
Publicado: (2011) -
Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm
por: Truong, Daniel D., et al.
Publicado: (2013) -
Real-World Dosing of OnabotulinumtoxinA and IncobotulinumtoxinA for Cervical Dystonia and Blepharospasm: Results from TRUDOSE and TRUDOSE II
por: Kent, Ruth, et al.
Publicado: (2021) -
Sexual dysfunction in cervical dystonia and blepharospasm
por: Marek, M, et al.
Publicado: (2018)